Munich-based Twogee Biotech has announced the completion of a €2.16 million seed financing round. The investment is led by High-Tech Gründerfonds and Bayern Kapital, with the participation of strategic partners such as AgriFoodTech Venture Alliance and Heinz Entsorgung.

Focus on second-generation biomass

Founded in 2024 by Frank Wallrapp and Helge Jochens, Twogee Biotech focuses on converting low-value biomass residues into sustainable second-generation raw materials. The company supports industrial partners in the production of sugars for synthetic biology applications.

Predictive development platform

Twogee Biotech's approach is based on a predictive development platform that integrates enzyme screening, strain engineering, and fermentation. This allows for more efficient biomass utilization, reducing development times and scale-up risks for industrial partners.

Decentralized licensing model

Twogee Biotech aims for a licensing model that allows for local enzyme production at customer sites. This approach aims to reduce costs and emissions, supporting decentralized, circular value chains. Initial MVPs and paid pilot projects with industrial partners have already been completed.